TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The antibiotic linezolid when given for the treatment of multi-drug resistant tuberculosis is
safe and tolerated at a low dose (600 mg daily) for a limited duration (16 weeks)
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Centers for Disease Control and Prevention
Collaborators:
Columbia University University of KwaZulu Yale University